Skip to main content

Table 1 Comparison of patients’ characteristics between the non-RP and RPgroups

From: Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receiving radiotherapy: a retrospective multi-center radiogenomics study

Variables

non-RP group

(N = 71)

RP group

(N = 29)

p

Gender

Male

60(84.5)

27(93.1)

0.405

 

Female

11(15.5)

2(6.9)

 

Age

≤ 60

33(46.5)

13(44.8)

0.880

 

>60

38(53.5)

16(55.2)

 

Smoking status

Never

18(25.4)

7(24.1)

0.899

 

Former/current

53(74.6)

22(75.9)

 

Tumor location

Right Lung

38(53.5)

16(55.2)

1.000

 

Left Lung

31(43.7)

12(41.4)

 
 

Others

2(2.8)

1(3.4)

 

Histology

ADC

28(39.4)

6(20.7)

0.073

 

SCC

43(60.6)

23(79.3)

 

Clinical stage

IIIA

32(45.1)

10(34.5)

0.260

 

IIIB

34(47.9)

14(48.3)

 
 

IIIC

5(7.0)

5(17.2)

 

Radiation dose

≥60 Gy

57(80.3)

21(72.4)

0.389

 

≤ 60 Gy

14(19.7)

8(27.6)

 

Chemoradiotherapy

SCRT

30(42.3)

15(51.7)

0.388

 

CCRT

41(57.7)

14(48.3)

 

Radiation therapy

3D-CRT

15(21.1)

9(31.0)

0.292

 

IMRT

56(78.9)

20(69.0)

Â